APTOFUSE

Medical, pharmaceutical and surgical products for nucleic acid implants of the spine, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; chemical substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; filling substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; bio-absorbable filling substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; injectable viscoelastic substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; injectable dermal filler in the nature of biocompatible silicone for nucleic acid implants

Surgical nucleic implants for vertebrae; surgical nucleoarthoplasty implants for vertebrae; surgical nucleic implants based on filling substances for vertebrae; surgical implants for intervertebral discs; surgical nucleic implants based on injectable biocompatible silicone; surgical implants for intervertebral discs; surgical implants based on bone substitutes; bone substitutes, intervertebral bone substitutes, allograft bone substitutes, synthetic bone substitutes